EDGAR Filing Documents for 0001654954-18-008404

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001654954-18-008404

Filing Date

2018-08-03

Accepted

2018-08-03 09:16:57

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	gtbp_s3.htm	424B3	636433
2	IMAGE	gtbp_s3000.jpg	GRAPHIC	4167
3	IMAGE	gtbp_s3001.jpg	GRAPHIC	5413
	Complete submission text file	0001654954-18-008404.txt		651188

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)